Colgate Shares Rise 4% After Q4 Earnings Beat

Core Insights - Colgate-Palmolive reported fourth-quarter earnings and revenue that exceeded expectations, with shares rising over 4% intraday [1] - The company faced a significant impairment charge of $794 million related to its skin health business, impacting GAAP earnings [2] - For full-year 2025, Colgate's net sales increased to $20.38 billion, with adjusted earnings per share rising to $3.69 [3] Financial Performance - Adjusted earnings per share for the fourth quarter were $0.95, surpassing analyst estimates of $0.91 [1] - Revenue for the quarter reached $5.23 billion, exceeding consensus forecasts of $5.12 billion, marking a year-over-year increase of 5.8% [1] - Organic sales growth for the quarter was 2.2%, excluding currency impacts and acquisitions [1] Regional Performance - Latin America showed strong performance with reported sales rising 12.8% and organic growth of 6.5% [2] - The Africa/Eurasia region also experienced robust gains, with reported sales up 15% and organic growth of 10.3% [2] Future Projections - For 2026, Colgate projected net sales growth of 2% to 6%, including a low-single-digit benefit from foreign exchange [3] - Organic sales are expected to rise by 1% to 4% [3] - The company anticipates gross margin expansion, increased advertising investment, and low- to mid-single-digit EPS growth on a non-GAAP basis [3]